Interview with Filya Zhebrovska, Chairman of the Supervisory Board of Farmak JSC

Farmak, a leader in the Ukrainian market of medicines*, was included in TOP 50 of Best Employers of Ukraine, which was composed by Forbes jointly with recruitment website Robota.ua. While making the rating, Forbes and Robota.ua considered company employees’ questionnaires, opinions of recruiting experts, industry-specific editors of the outlet, and informati...

Farmak, a leader of the medicinal market in Ukraine, took part in the first meeting of the Critical Medicines Alliance Forum. The Alliance was launched by the European Commission in response to the Covid-19 Coronavirus pandemic. Its core task is to reduce the risk of deficit of essential medicines in the EU during the next […]

As of 27 March 2024, Farmak’s International Office has successfully finalized its acquisition of Symphar, becoming the sole owner of the Polish pharmaceutical company. The acquisition represents a part of Farmak’s international expansion strategy “Farmak 2.0: From local to global success”. This M&A is an important next step after last year’s ...